Document Detail


Tamoxifen and the factor V Leiden mutation.
MedLine Citation:
PMID:  20554943     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Jack Cuzick
Related Documents :
16115133 - Gene conversions are a common cause of von willebrand disease.
10941343 - Association of the prothrombin g20210a mutation with factor v leiden in a midwestern am...
21488193 - Association of β₂-adrenergic receptor polymorphism with work-related symptoms in wor...
Publication Detail:
Type:  Comment; Editorial     Date:  2010-06-16
Journal Detail:
Title:  Journal of the National Cancer Institute     Volume:  102     ISSN:  1460-2105     ISO Abbreviation:  J. Natl. Cancer Inst.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-07     Completed Date:  2010-07-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7503089     Medline TA:  J Natl Cancer Inst     Country:  United States    
Other Details:
Languages:  eng     Pagination:  918-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents, Hormonal / administration & dosage,  adverse effects*
Breast Neoplasms / drug therapy*
Estrogen Receptor Modulators / administration & dosage,  adverse effects*
Factor V / genetics*
Female
Humans
Mutation*
Prevalence
Risk Factors
Tamoxifen / administration & dosage,  adverse effects*
Thromboembolism / chemically induced,  etiology*,  genetics
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Hormonal; 0/Estrogen Receptor Modulators; 0/factor V Leiden; 10540-29-1/Tamoxifen; 9001-24-5/Factor V
Comments/Corrections
Comment On:
J Natl Cancer Inst. 2010 Jul 7;102(13):942-9   [PMID:  20554945 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Ameri...
Next Document:  Essential Role of TRPC6 Channels in G2/M Phase Transition and Development of Human Glioma.